Werbung
Werbung

LSTA

LSTA logo

Lisata Therapeutics, Inc. Common Stock

1.98
USD
Gesponsert
-0.08
-3.98%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

2.01

+0.03
+1.62%

LSTA Ergebnisberichte

Positives Überraschungsverhältnis

LSTA übertreffen die 27 der letzten 40Schätzungen.

68%

Nächster Bericht

Datum des nächsten Berichts
25. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.52
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
+6.12%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-5.45%

Lisata Therapeutics, Inc. Common Stock earnings per share and revenue

On 06. Nov. 2025, LSTA reported earnings of -0.49 USD per share (EPS) for Q3 25, beating the estimate of -0.54 USD, resulting in a 10.21% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.52 USD, with revenue projected to reach -- USD, implying an increase of 6.12% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Lisata Therapeutics, Inc. Common Stock reported EPS of -$0.49, beating estimates by 10.21%, and revenue of $0.00, 0% as expectations.
The stock price moved down -12.34%, changed from $2.35 before the earnings release to $2.06 the day after.
The next earning report is scheduled for 25. Feb. 2026.
Based on 4 analysts, Lisata Therapeutics, Inc. Common Stock is expected to report EPS of -$0.52 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung